Antiproliferative miR-212-5p: Promising RNA therapy for pulmonary hypertension

• Francisco Perez-Vizcaino,
• Gema Mondejar-Parreño

Affiliations

Francisco Perez-Vizcaino

Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain; CIBER Enfermedades Respiratorias (Ciberes), Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid, Spain; Corresponding author Francisco Perez-Vizcaino, PhD, Department of Pharmacology and Toxicology. School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.

Gema Mondejar-Parreño

Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA